RT @mreyesm: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/aRXCCV6mw3. No survival impr…
Immediate complete lymph-node dissection doesn't increase survival in melanoma patients with sentinel-node mets https://t.co/TdSaMYJOhg
RT @Skepticscalpel: No diff in survival. Completion LN Dissection or Observation for Sentinel-Node Metastasis in Melanoma—NEJM https://t.co…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
No diff in survival. Completion LN Dissection or Observation for Sentinel-Node Metastasis in Melanoma—NEJM https://t.co/NX0Vvulebc
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
RT @TawnyaBowles: This study will change rx of SLN+ #melanoma. #Utah pts helped make this study happen. @IntermtnMedCtr @huntsmancancer htt…
RT @MarcelaSaebL: #melanoma #pathology #dermatopathology must read! https://t.co/GlHQSHp3SD
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/bh2WT04iqJ
Important RCT on melanoma and lymph node dissection in the NEJM today. https://t.co/RU42ODaJGs
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. #amchelsinki https://t.co/YyyWhmle5s
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. https://t.co/uY7IAHEjjI
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. https://t.co/KTmTNN7Uej
RT @JimCatto: Limited impact of extent of lymphadenectomy in melanoma. Lessons for other cancers? https://t.co/lWCcZHRdtY
RT @ashlie_nadler: MSLT-II: This will change how we manage melanoma! https://t.co/khVhdYs0e4
RT @JimCatto: Limited impact of extent of lymphadenectomy in melanoma. Lessons for other cancers? https://t.co/lWCcZHRdtY
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/loXI4QG8Mm
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @Melanoma_MMP: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/70UMbmo6Iq
RT @fischmd: Completion dissection does not incr #melanoma-specific survival. Lymphedema in 24.1% of the pts in the dissection group vs 6.3…
Limited impact of extent of lymphadenectomy in melanoma. Lessons for other cancers? https://t.co/lWCcZHRdtY
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @JHuiMD: MSLT-II: node dissection (vs observation) confers no #melanoma specific survival benefit in SLN +ve pts @ 3 yrs https://t.co/6…
RT @TawnyaBowles: This study will change rx of SLN+ #melanoma. #Utah pts helped make this study happen. @IntermtnMedCtr @huntsmancancer htt…
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/70UMbmo6Iq
RT @DrewMoghanaki: Once again, a study shows that removing the LN's is akin to removing speedometers. It doesn't disengage the engine. http…
Results of MSLT II out in @nejm. https://t.co/khNpZbOrPY
This study will change rx of SLN+ #melanoma. #Utah pts helped make this study happen. @IntermtnMedCtr @huntsmancancer https://t.co/WuUYCGORlr
So,observation with ultrasound.Completion Dissection or Observation for Centinela-Node Metastasis in Melanoma — NEJM https://t.co/8EvZ1wUnAp
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
Mgmt of +regional lymph nodes in melanoma - completion LN dissection vs postop observation & serial nodal ultrasound https://t.co/9CYYaJeSQK https://t.co/aJjF51NDYS
Once again, a study shows that removing the LN's is akin to removing speedometers. It doesn't disengage the engine. https://t.co/UGZMp0FWmz
RT @ashlie_nadler: MSLT-II: This will change how we manage melanoma! https://t.co/khVhdYs0e4
MSLT-II: This will change how we manage melanoma! https://t.co/khVhdYs0e4
RT @weldeiry: Completion Dissection or Observation for Sentinel-Node Mets in Melanoma— NEJM https://t.co/nPCw3VV8g6 Congrats @Jeffreyfarma…
Completion Dissection or Observation for Sentinel-Node Mets in Melanoma— NEJM https://t.co/nPCw3VV8g6 Congrats @Jeffreyfarma @foxchasecancer
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
RT @mreyesm: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/aRXCCV6mw3. No survival impr…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
My personal bias has always been positive nodes provide prognostic info, but removal does not extend survival (melanoma and others). MSLT-2 https://t.co/XDemrgqrEt
MSLT- 2 trial results are out! What do people think of them? https://t.co/0BHJ8oPk0v
RT @mreyesm: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/aRXCCV6mw3. No survival impr…
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/5DDAyaFUUj
RT @fischmd: Completion dissection does not incr #melanoma-specific survival. Lymphedema in 24.1% of the pts in the dissection group vs 6.3…
Reseccion versus observacion de ganglio centinela en melanoma metastasico. https://t.co/JVboLL7UDI
RT @JHuiMD: MSLT-II: node dissection (vs observation) confers no #melanoma specific survival benefit in SLN +ve pts @ 3 yrs https://t.co/6…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @JHuiMD: MSLT-II: node dissection (vs observation) confers no #melanoma specific survival benefit in SLN +ve pts @ 3 yrs https://t.co/6…
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
MSLT-II: node dissection (vs observation) confers no #melanoma specific survival benefit in SLN +ve pts @ 3 yrs https://t.co/6rppzAFlAD
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/sNxq7YaRnN
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
RT @SocPediPath: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival…
Surgery Vs observation for #melanoma with sentinel-node #metastasis; Ph3 trial data @NEJM shows no difference in #melanoma-specific survival https://t.co/RUmFiTdmJW
MSLT-2 publicado. Sem ganho de sobrevida com a dissecção linfonodal. Alguma surpresa? https://t.co/C8UQJMQJId
MSLT-2 published. No survival benefit? Is this a surprise? https://t.co/C8UQJMQJId
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/KOaJnmWIZh. No survival improvement...
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/aRXCCV6mw3. No survival improvement...
RT @jeffreyfarma: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/EazRwStVD7
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma — NEJM https://t.co/EazRwStVD7
RT @fischmd: Completion dissection does not incr #melanoma-specific survival. Lymphedema in 24.1% of the pts in the dissection group vs 6.3…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
Completion dissection does not incr #melanoma-specific survival. Lymphedema in 24.1% of the pts in the dissection group vs 6.3%. #melsm https://t.co/azKogBP94u
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…
RT @NEJM: Original Article: Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma https://t.co/0cbNEb5yB3 https://t…